Skip to main content
. 2008 May 6;19(2):188–194. doi: 10.1111/j.1750-3639.2008.00170.x

Table 3.

Multivariate analysis for the effect of TP53 codon 72 polymorphism on survival of glioblastoma patients.

TP53 Wild‐type TP53 Mutated
No. of cases Hazard ratio*
(95% CI) No. of cases Hazard ratio*
(95% CI)
TP53 codon 72
 Arg/Arg 130 1 58 1
 Arg/Pro, Pro/Pro 93 1.06 (0.81–1.39) 43 1.66 (1.07–2.56)
*

This model is adjusted for age, gender and treatment.